Thellim carefully sidles away from the wine.  On second thought, she will not be exploring the space of mind-altering drugs developed by a tiny region with no standard-professional-ethical-codes that does not know what neurons are.  She's afraid to even ask what the experimental protocols were like before this product was rolled out.  Two patient groups of size N=12 with the results recorded in crayon, she's guessing.

Thellim carefully sidles away from the wine.  On second thought, she will not be exploring the space of mind-altering drugs developed by a tiny region with no standard-professional-ethical-codes that does not know what neurons are.  She's afraid to even ask what the experimental protocols were like before this product was rolled out.  Two patient groups of size N=12 with the results recorded in crayon, she's guessing.